Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.41 USD | -2.00% | -3.50% | +66.42% |
08/05 | Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
07/05 | Piper Sandler Upgrades Design Therapeutics to Overweight From Neutral | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+66.42% | 25Cr | |
+33.63% | 5.09TCr | |
-0.09% | 4.21TCr | |
+49.62% | 4.2TCr | |
-4.96% | 2.92TCr | |
+11.18% | 2.6TCr | |
-21.95% | 1.89TCr | |
+8.61% | 1.32TCr | |
+24.73% | 1.22TCr | |
+28.31% | 1.22TCr |
- Stock Market
- Equities
- DSGN Stock
- News Design Therapeutics, Inc.
- RBC Cuts Price Target on Design Therapeutics to $24 From $29, Maintains Outperform Rating, Speculative Risk Qualifier